scispace - formally typeset
M

Michel P. Glauser

Researcher at University Hospital of Lausanne

Publications -  100
Citations -  11099

Michel P. Glauser is an academic researcher from University Hospital of Lausanne. The author has contributed to research in topics: Septic shock & Lipopolysaccharide. The author has an hindex of 47, co-authored 100 publications receiving 10922 citations. Previous affiliations of Michel P. Glauser include University of Lausanne & Institut Jules Bordet.

Papers
More filters
Journal ArticleDOI

Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a Mutant Escherichia coli

TL;DR: It is concluded that human antiserum to the lipopolysaccharide core can substantially reduce deaths from gram-negative bacteremia and endotoxin shock.
Journal ArticleDOI

Protection from septic shock by neutralization of macrophage migration inhibitory factor.

TL;DR: It is reported here that macrophage migration inhibitory factor (MIF) is a critical mediator of septic shock and a new target for therapeutic intervention is identified.
Journal ArticleDOI

Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors

TL;DR: Administration of PIs to HIV-infected individuals is associated with a marked, compound-specific dyslipidemia, and the risk of pancreatitis and premature atherosclerosis due to PI-associated dys Lipoprotein remains to be established.
Journal ArticleDOI

MIF regulates innate immune responses through modulation of Toll-like receptor 4

TL;DR: It is reported that MIF is an essential regulator of macrophage responses to endotoxin (lipopolysaccharide) and Gram-negative bacteria and provides a molecular basis for the resistance of MIF-deficient mice to endotoxic shock.
Journal ArticleDOI

Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon-α, and Interferon-γ in the Serum of Patients with Septic Shock

TL;DR: In patients with septic shock due to various gram-negative bacteria, other parameters than the absolute serum concentration of immunoreactive TNF contributed significantly to the prediction of outcome.